{"result": "(\"entity\"<|>HIPONATREMIA EUVOLÉMICA<|>EVENT<|>Hiponatremia euvolémica is a common type of hyponatremia in hospitalized patients, characterized by normal or elevated effective circulating volume due to non-osmotic secretion of ADH.)\n##\n(\"entity\"<|>SIADH<|>EVENT<|>Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH) is a condition that causes hyponatremia due to excessive release of ADH.)\n##\n(\"entity\"<|>ACTH<|>EVENT<|>Adrenocorticotropic hormone (ACTH) is a hormone that stimulates the production of cortisol and is involved in the regulation of aldosterone levels.)\n##\n(\"entity\"<|>CORTISOL<|>EVENT<|>Cortisol is a steroid hormone produced by the adrenal glands, important for metabolism and stress response.)\n##\n(\"entity\"<|>NE<|>EVENT<|>NE refers to a condition involving patients with swallowing disorders, often secondary to neurological pathologies.)\n##\n(\"entity\"<|>NP<|>EVENT<|>NP refers to a condition where patients have undergone abdominal surgery, often due to digestive neoplasia, and may experience nausea and vomiting.)\n##\n(\"entity\"<|>HIPOALDOSTERONISMO<|>EVENT<|>Hypoaldosteronism is a condition characterized by low levels of aldosterone, which can lead to hyponatremia.)\n##\n(\"entity\"<|>HEMORRAGIA SUBARACNOIDEA<|>EVENT<|>Subarachnoid hemorrhage is a medical condition where bleeding occurs in the space surrounding the brain, which can lead to various complications including hyponatremia.)\n##\n(\"relationship\"<|>HIPONATREMIA EUVOLÉMICA<|>SIADH<|>Hiponatremia euvolémica can be caused by SIADH, which leads to inappropriate secretion of ADH<|>8)\n##\n(\"relationship\"<|>HIPONATREMIA EUVOLÉMICA<|>ACTH<|>The diagnosis of hiponatremia euvolémica involves evaluating ACTH levels to rule out adrenal insufficiency<|>6)\n##\n(\"relationship\"<|>HIPONATREMIA EUVOLÉMICA<|>CORTISOL<|>Cortisol levels are assessed in patients with hiponatremia euvolémica to determine if there is an underlying adrenal issue<|>6)\n##\n(\"relationship\"<|>NE<|>HIPONATREMIA EUVOLÉMICA<|>Patients with NE may develop hiponatremia euvolémica due to their underlying neurological conditions<|>5)\n##\n(\"relationship\"<|>NP<|>HIPONATREMIA EUVOLÉMICA<|>Patients with NP may experience hiponatremia euvolémica as a result of their surgical history and associated symptoms<|>5)\n##\n(\"relationship\"<|>HIPOALDOSTERONISMO<|>HIPONATREMIA EUVOLÉMICA<|>Hypoaldosteronism can lead to hiponatremia euvolémica due to insufficient aldosterone levels<|>7)\n##\n(\"relationship\"<|>HEMORRAGIA SUBARACNOIDEA<|>HIPONATREMIA EUVOLÉMICA<|>Subarachnoid hemorrhage can result in hiponatremia euvolémica in a significant number of patients<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: debe descartar in-                      la  hiponatremia        euvolémica      asociada      a  la  «familia\n      suficiencia suprarrenal primaria (cortisol basal < 5                    ADH» sea también el tipo más frecuente de hiponatre-\n      μg/dl y/o < 18          μg/dl tras estímulo con ACTH,                   mia. Entre otros motivos, por el tipo de paciente que\n      acompañado de ACTH elevada)58 y posteriormente                          recibe este soporte nutricional. En el caso de la NE, se\n      calcular el GTTK [k+o x (Osmp / Osm) / K+]. Una cifra                   trata de pacientes con alteración de la deglución habi-\n                                                  o      p                    tualmente secundaria a patología neurológica de base\n      inferior a 5 confirma la disfunción del receptor mi-                    (accidente      cerebrovascular,       traumatismo         craneoen-\n      neralocorticoide. La ausencia de incremento del                         cefálico, hemorragia subaracnoidea, enfermedad de-\n      GTTK tras la administración de 0,05 mg de fludro-                       generativa, etc.) y a patología neoplásica de cabeza y\n      cortisona sugiere una resistencia del receptor mine-                    cuello tratada bien con cirugía o con radioterapia. To-\n      ralocorticoideo y el aumento del GTTK indica un                         das estas patologías se han descrito como causa de\n      déficit de aldosterona52. Este hipoaldosteronismo                       SIADH30. Respecto a la NP, la mayoría de los pacientes\n      podrá ser primario con renina elevada (fármacos                         han sido sometidos previamente a una cirugía abdomi-\n      inhibidores del SRAA, heparina, etc.) o secundario                      nal (en la mayoría de los casos justificada por neoplasia\n      con cifras de renina bajas (AINE, nefropatía diabéti-                   digestiva) acompañada de náuseas, vómitos y dolor.\n      ca, etc.). Por último, el síndrome pierde sal cerebral                  Así como, de fármacos opiáceos para el control del do-\n      es una causa infrecuente de hiponatremia hipovolé-                      lor. De hecho, en un estudio prospectivo de pacientes\n      mica. En un estudio prospectivo reciente de 100                         con NP e hiponatremia, se objetivó hiponatremia euvo-\n      pacientes con hemorragia subaracnoidea e hipona-                        lémica en el 75% pacientes (2/3 fueron diagnosticados\n      tremia no se detectó ni un solo caso59.                                 de SIADH y el resto de elevación fisiológica de la ADH\n4.2.3.3.     Hiponatremia euvolémica                                          por dolor)61. Otras causas de hiponatremia euvolémica\n                                                                              como la intoxicación aguda de agua, la polidipsia pri-\n   La hiponatremia euvolémica es el tipo de hiponatre-                        maria y el déficit de sal, son infrecuentes en pacientes\nmia más común en población hospitalaria, con una\nfrecuencia de un 43-48%23, 54 . Entre sus causas, la prin-                    con NP. Respecto al déficit de sal, en este grupo de\n                                                                              pacientes se ha encontrado un desarrollo de hipona-\ncipal es la mediada por ADH o «familia ADH», pacien-                          tremia independiente del bajo aporte de sodio62. En\ntes con volumen circulante efectivo (VCEF) normal o                           ausencia de pérdidas corporales de sodio o una eleva-\nelevado por una hipersecreción no osmótica de ADH                             ción no osmótica de la ADH, un paciente con bajo\nno inducida por el estímulo barorreceptor. Este grupo                         aporte de sal solo desarrolla hiponatremia si no dispo-\ncomprende el SIADH, la hiponatremia por déficit de                            ne del suficiente soluto en la médula renal para elimi-\nACTH (cortisol basal < 11            μg/dl y en situaciones de                nar todo el líquido aportado24. Esta última situación es\n                  Tabla 2.   Criterios esenciales para el diagnóstico del SIADH. Adaptada de Ellison DH\n                  et al. New England J Med, 2007.\n\n\n\n                   · Osm plasmática < 275 mOsmol/kg\n                   · OsmU inapropiada para la hiposmolalidad plasmática (OsmU > 100 mOsm/kg)\n                   · Euvolemia clínica\n                   · NaU > 40 mmol/l, en presencia de una ingesta suficiente de sal\n                   · No uso reciente de diuréticos\n                   · Ausencia de insuficiencia suprarrenal secundaria e hipotiroidismo severo\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}